SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-160545
Filing Date
2019-05-30
Accepted
2019-05-30 10:26:05
Documents
9
Period of Report
2019-05-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d751870d6k.htm 6-K 1207558
2 GRAPHIC g751870g07c64.jpg GRAPHIC 8420
3 GRAPHIC g751870g10p10.jpg GRAPHIC 30037
4 GRAPHIC g751870g10p11.jpg GRAPHIC 28103
5 GRAPHIC g751870g10p12.jpg GRAPHIC 26157
6 GRAPHIC g751870g10p13.jpg GRAPHIC 35622
7 GRAPHIC g751870g10p14.jpg GRAPHIC 45778
8 GRAPHIC g751870g10p15.jpg GRAPHIC 49685
9 GRAPHIC g751870i1.jpg GRAPHIC 3866
  Complete submission text file 0001193125-19-160545.txt   1523242
Mailing Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
Business Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 19865021
SIC: 2834 Pharmaceutical Preparations